Sunday, September 13, 2020 5:46:55 PM
Comparing the data I've looked at for Lenzilumab ( HGEN ) vs RLF-100 ...so far ...HGEN study of 39 patients and RLFTF's open label data ....RLF-100 looks to be the better drug
BUT double blinded placebo controlled data from both will ultimately answer that question .
Re RVVTF. as front runner ? I think you meant RLFTF ...RVVTF doesn't have the funding ( as least as far as I can find ) to mount a P 3 trial . HGEN is well funded and RLFTF certainly now has enough $ to finish the IV trial and at least start the Inhaler trial
Kiwi
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM
POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • POET • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM